Fibrinogen Dusart: Electron microscopy of molecules, fibers and clots, and viscoelastic properties of clots

Biophysical Journal

Volumn 70, Issue 1, 1996, Pages 500-510

  Collet, Jean Philippe ^a,b   Woodhead, John L ^a   Soria, Jeannette ^b   Soria, Claudine ^c   Mirshahi, Manouchehr ^b   Caen, Jacques P ^d   Weisel, John W ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b HÔTEL DIEU   (France)

^c UNIVERSITÉ DE ROUEN   (France)

^d HÔPITAL LARIBOISIÈRE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

FIBRINOGEN;

AMINO ACID SUBSTITUTION; ARTICLE; BLOOD CLOTTING; CARBOXY TERMINAL SEQUENCE; CELL ULTRASTRUCTURE; DYSFIBRINOGENEMIA; ELECTRON MICROSCOPY; FIBRIN CLOT; HUMAN; HUMAN CELL; PROTEIN DOMAIN; VISCOELASTICITY;

EID: 0030068432     PISSN: 00063495     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-3495(96)79596-6     Document Type: Article

References (54)

1. Baradet, T. C., J. C. Haselgrove, and J. W. Weisel. 1995. Three-dimensional reconstruction of fibrin clot networks from stereoscopic intermediate voltage electron microscope images and analysis of branching. Biophys. J. 68:1551-1560.
2. Blombäck, B., and M. Blombäck. 1956. Purification of human and bovine fibrinogen. Arkiv Kemi. 10:415-443.
3. Blomback, B., M. Blombäck, K. Carlsson, K. Fatah, A. Hamsten, and B. Hessel. 1992. Fibrin gel structure in health and disease In Fibrinogen: A New Cardiovascular Risk Factor, E. Ernst, W. Koenig, G. D. O. Lowe, and T. W. Meade, editors. Blackwell, London. 11-18.
4. Carr, M. E, and D. A. Gabriel. 1980. The effect of dextran 70 on the structure of plasma derived fibrin gels. J. Lab. Clin. Med. 96:985-993.
5. Cierniewski, C. S., and A. Z. Budzynski. 1992 Involvement of the α chain in fibrin clot formation. Effect of monoclonal antibodies. Biochemistry. 31:4248-4253.
6. Collet, J. P., J. Soria, M. Mirshahi, M. Hirsch, F. B. Dagonnet, J. Caen, and C. Soria. 1993. Dusart syndrome: a new concept of the relationship between fibrin clot architecture and fibrin clot degradability: hypofibrinolysis related to an abnormal clot structure. Blood. 82:2462-2469.
7. Dhall, T. Z., W. A. J. Bryce, and D. P. Dhall. 1976. Effects of dextran on the molecular structure and tensile behavior of human fibrin. Thromb. Haemostasis. 35:737-745.
8. Ebert, R. F 1994. Index of Variant Human Fibrinogens. CRC Press, Boca Raton.
9. Erickson, H. P., and W. E. Fowler. 1983, Electron microscopy of fibrinogen, its plasmic fragments and small polymers. Ann. NY Acad Sci. 408:146-163.
10. Fatah, K., A. Hamsten, B. Blombäck. and M. Blombäck. 1992. Fibrin gel network characteristics and coronary heart disease. relations to plasma fibrinogen concentration, acute phase protein, serum lipoproteins and coronary heart disease. Thromb. Haemost. 68:130-135.
11. Ferry, J. D. 1988. Structure and rheology of fibrin networks. In Biological and Synthetic Polymer Networks. O. Kramer, editor. Elsevier, Amsterdam. 41-55.
12. Fowler, W. E., and H. P. Erickson. 1979. Trinodular structure of fibrinogen: confirmation by both shadowing and negative-stain electron microscopy. J. Mol. Biol. 134:241-249.
13. Gabriel, D. A., K. Muga, and E. M. Boothroyd. 1992. The effect of fibrin structure on fibrinolysis. J. Biol. Chem. 267:24259-24263.
14. Galanakis, D. K. 1991. Heterozygous Aα16Arg→Cys dysfibrinogenemia: characterization of mutant molecule rich isolates. Thromb. Haemostasis. 65:899a.
15. Galanakis, D. K., A. Henschen, M. Keeling, and M. Kehl. 1983. Fibrinogen Louisville: an Aα16Arg→His defect which forms no hybrid molecules in heterozygous individuals and inhibits aggregation of normal fibrin monomers. Ann. NY Acad. Sci. 408:644-648.
16. Galanakis, D. K., A. Henschen, E. I. Peerschke, and M. Kehl. 1989. Fibrinogen Stony Brook, a heterozygous Aα16Arg→Cys dysfibrinogenemia: evaluation of diminished platelet aggregation support and of enhanced inhibition of fibrin assembly. J. Clin. Invest. 84:295-304.
17. Galanakis, D. K., and M. Hultin. 1990 Fibrinogen Stony Brook II: A heterozygously transmitted peptide A defect. Evidence that most mutant molecules are homodimers. Blood. 76:421a.
18. Gerth, C., W. W. Roberts, and J. D. Ferry. 1974. Rheology of fibrin clots. II. Linear viscoelastic behavior in shear creep. Biophys. Chem. 2:208-217.
19. Gorkun, O. V., Y. I. Veklich, L. V. Medved', A. H. Henschen, and I. W. Weisel. 1994. Role of the αC domains in fibrin formation. Biochemistry. 33:6986-6997.
20. Hasegawa, N., and S. Sasaki. 1990. Location of the binding site "b" for lateral polymerization of fibrin. Thromb. Res. 57:183-195.
21. Holm, B., F. Brosstad, P. Kierulf, and H. C. Godal. 1985. Polymerization properties of two normally circulating fibrinogens, HMW and LMW. Evidence that the COOH-terminal end of the α-chain is of importance for fibrin polymerization. Thromb. Res. 39:595-606.
22. Hoylaerts, M., D. C. Rijken, H. R. Lijnen, and D. Collen. 1982. Kinetics of the activation of plasminogen by human tissue plasminogen activator. J. Biol. Chem. 257:2912-2919.
23. Janmey, P. A. 1991. A torsion pendulum for measurement of the viscoelasticity of biopolymers and its application to actin networks. J. Biochem Biophys. Methods. 22:41-53.
24. Janmey, P. A., U. Euteneuer, P. Traub, and M. Schliwa. 1991. Viscoelastic properties of vimentin compared with other filamentous biopolymer networks. J. Cell. Biol. 113:155-160
25. Koopman, J., F. Haverkate, J Grimbergen, R. Egbring, and S. T. Lord. 1992. Fibrinogen Marburg: a homozygous case of dysfibrinogenemia, lacking amino acids Aα 461-610 (Lys 461 AAA →stop TAA). Blond. 80:1972-1979.
26. Koopman, J., F. Haverkate, J. Grimbergen, S. T. Lord, M Mosesson, J. P. DiOrio, K. S. Siebenlist, C. Legrand, J. Soria, C. Soria. and J. P. Caen. 1993. Molecular basis for fibrinogen Dusart (Aα 554 Arg→Cys) and its association with abnormal fibrin polymerization and thrombophilia. J. Clin. Invest. 91:1637-1643.
27. Langer, B. G., J. W. Weisel, P. A. Dinauer, C. Nagaswami, and W. R. Bell. 1988. Deglycosylation of fibrinogen accelerates polymerization and increases lateral aggregation of fibrin fibers. J. Biol. Chem. 263: 15056-15063.
28. Lau, H. K. F. 1993. Anticoagulant function of a 24-Kd fragment isolated from human fibrinogen Aα chains. Blood. 81:3277-3284.
29. Lee, M. H., E. Kaczmarek, D. T. Chin, A. Oda, S. McKintosh, K. A. Bauer, L. P Clyne, and J. P. McDonagh. 1991. Fibrinogen Ledyard (AαArg → Cys): biochemical and physical characterization. Blood. 78:1744-1752.
30. Lijnen, H. R , J Soria, C. Soria, D. Collen, and J. P. Caen. 1984. Dysfibrinogenemia (fibrinogen Dusart) associated with impaired enhancement of plasminogen activation. Thromb. Haemostasis. 51:108-109.
31. Maekawa, H., K. Yamazumi, S. Muramatsu, M. Kaneko, H. Hirata, N. Takahashi, N. B. deBosch, Z. Carvajal, A. Ojeda, C. L. Arocha-Pinango, and M. Matsuda. 1991. An Aα Ser-434 to N-glycosylated Asn substitution in a dysfibrinogen, fibrinogen Caracas II, characterized by impaired fibrin gel formation. J. Biol. Chem. 266:11575-11581.
32. McDonagh, J. 1994. Suppression of plasminogen binding to fibrin by high fibrinogen: a mechanism for how high fibrinogen enhances the risk of thrombosis. Sanofi Assoc. Thromb. Res. 4:I-XX.
33. Medved', L. V., O. V. Gorkun, V. F. Manyakov, and V. A. Belitser. 1985. The role of fibrinogen α C-domains in the fibrin assembly process. FEBS Lett. 181:109-112.
34. Medved', L., T. Ugarova, Y. Veklich, N. Lukinova, and J. Weisel. 1990, Electron microscope investigation of the early stages of fibrin assembly. Twisted protofibrils and fibers. J. Mol. Blol. 216:503-509.
35. Mosesson, M. W , N. Alkjaersig, B. Sweet, and S. Sherry. 1967. Human fibrinogen of relatively high solubility. Comparative biophysical, biochemical, and biological studies with fibrinogen of lower solubility. Biochemistry. 6:3279-3287.
36. Nelb, G. W., C. Gerth, J. D. Ferry, and L. Lorand. 1976. Rheology of fibrin clots. III. Sheer creep and creep recovery of fine ligated and coarse unligated clots. Biophys. Chem. 5:377-387.
37. Plazek, D. J., M. N. Vrancken, and J. W. Berge. 1958 A torsion pendulum for dynamic creep measurements of soft viscoelastic materials. Trans. Soc. Rheol. 2:39-51.
38. Roberts, W. W., O. Kramer, R. W. Rosser, F. H. M. Nestler, and J. D. Ferry. 1974. Rheology of fibrin clots. I. Dynamic viscoelastic properties and fluid permeation. Biophys. Chem. 1:152-160.
39. Roberts, W. W., L. Lorand, and L. F. Mockros. 1973 Viscoelastic properties of fibrin clots. Biorheolagy. 10:29-42.
40. Scrutton, M. C., S. B. Ross-Murphy, G. M. Bennett, Y. Stirling, and T. W. Meade. 1994. Changes in clot deformability: a possible explanation for the epidemiological association between plasma fibrinogen concentration and myocardial infarction. Blood Coagul. Fibrinolysis. 5:719-723.
41. Siebenlist, K. R., M. W. Mosesson, J. P. DiOrio, J. Soria, C. Soria, and J. P. Caen. 1993. The polymerization of fibrinogen Dusart (Aα 554 Arg → Cys) after removal of carboxy terminal regions of the Aα-chains. Blood Coagul. Fibrinolysis 4:61-65.
42. Siebenlist, K. R., J. T. Prchal, and M. W. Mosesson. 1988. Fibrinogen Birmingham: a heterozygous dysfibrinogenemia (Aα Arg16 → His) containing heterodimeric molecules. Blood. 71:613-618.
43. Slayter, H. S 1983. Electron microscopic studies of fibrinogen structure: historical perspectives and recent experiments. Ann. NY Acad. Sci. 408:131-45.
44. Soria, J., C. Soria, and J. P. Caen. 1983. A new type of congenital dysfibrinogenemia with defective fibrin lysis: Dusart syndrome, possible relation to thrombosis. Brit. J Haematol. 53:575-586.
45. Veklich, Y. I., O. V. Gorkun, L. V. Medved, W. Nieuwenhuizen, and J. W. Weisel. 1993. Carboxyl terminal portions of the α chains of fibrinogen and fibrin: localization by electron microscopy and the effects of isolated αC fragments on polymerization. J. Biol. Chem. 268:13577-13585.
46. Wada, Y., and S. T. Lord. 1994. A correlation between thrombotic disease and a specific fibrinogen abnormality (Aα 554 Arg→Cys) in two unrelated kindred, Dusart and Chapel Hill III. Blood. 84:3709-3714.
47. Weisel, J. W. 1986a. The electron microscope band pattern of human fibrin: various stains, lateral order, and carbohydrate localization J Ultrastruct. Mol. Struct. Res. 96:176-188.
48. Weisel, J. W. 1986b. Fibrin assembly. Lateral aggregation and the role of the two pairs of fibrinopeptides. Biophys. J. 50:1079-1093.
49. Weisel, J. W. 1988. Structural studies of lateral aggregation in fibrin assembly. In Fibrinogen 3, Biochemistry, Biological Functions, Gene Regulation and Expression, M. W. Mosesson, D. L. Amrani, K. R. Siebenlist, and J. P. DiOrio, editors Excerpta Medica, Amsterdam. 113-116.
50. Weisel, J. W., and C. Nagaswami. 1992. Computer modeling of fibrin polymerization kinetics correlated with electron microscope and turbidity observations: clot structure and assembly are kinetically controlled. Biophys. J. 63:111-128.
51. Weisel, J. W., C. Nagaswami, B. Korsholm, L. C. Petersen, and E. Suenson. 1994. Interactions of plasminogen and polymerizing fibrin and its derivatives monitored with a photoaffinity cross-linker and electron microscopy. J. Mol. Biol 235: 1117-1135.
52. Weisel, J. W , C. Nagaswami, and L. Makowski. 1987. Twisting of fibrin fibers limits their radial growth. Proc. Natl. Acad. Sci. USA. 84:8991-8995.
53. Weisel, J. W., C. V. Stauffacher, E. Bullitt, and C. Cohen. 1985. A model for fibrinogen: domains and sequence. Science. 230:1388-1391.
54. Williams, R. C. 1983. Morphology of fibrinogen monomers and of fibrin protofibrils. Ann. NY Acad. Sci. 408:180-193.